Attentional Bias in Body Dysmorphic Disorder (VAB)
|ClinicalTrials.gov Identifier: NCT01398904|
Recruitment Status : Completed
First Posted : July 21, 2011
Last Update Posted : December 3, 2014
|Condition or disease|
|Body Dysmorphic Disorders|
|Study Type :||Observational|
|Actual Enrollment :||51 participants|
|Observational Model:||Case Control|
|Official Title:||Attentional Bias in Body Dysmorphic Disorder|
|Study Start Date :||March 2011|
|Primary Completion Date :||July 2012|
|Study Completion Date :||July 2012|
Body dysmorphic disorder (BDD) Participants
Participants must be 18 years or older with a primary diagnosis of body dysmorphic disorder (BDD), a BDD Yale-Brown Obsessive Compulsive Scale (BDDY-BOCS) score of >20, and a primary facial/head concern. Participants must have the ability to provide informed consent and understand study staff.
Males and females 18 years of age or older with ability to provide informed consent and understand study staff.
- Attention Pattern [ Time Frame: Day 2 ]Gaze tracking via an Eyelink II eye tracker will determine perception of visual information.
- Subjective Units of Distress Scale (SUDS) [ Time Frame: Day 2 ]Participants will provide a distress score based on the facial images observed.
- Facial Attractiveness [ Time Frame: Day 2 ]Using a 9-point Likert scale, participants will rate the perceived most attractive and unattractive feature of their own and the control face.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01398904
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Sabine Wilhelm, Ph. D.||Massachusetts General Hospital|
|Study Director:||Jennifer Greenberg, Psy. D.||Massachusetts General Hospital|